Join
Live feed
·
PRReleasevia Quantisnow
GSK plc logo
Summit Therapeutics Inc. logo

Summit Therapeutics Announces Clinical Trial Collaboration with GSK to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate (ADC)

ByQuantisnow·Wall Street's wire, on your screen.
GSK· GSK plcSMMT· Summit Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GSK (GSK plc), SMMT (Summit Therapeutics Inc.) and more on Quantisnow.